Keyphrases
1q22
25%
Carcinoma
33%
Codon
54%
Computed Tomography
33%
Cortisol
26%
Differential Diagnosis
23%
Fine Needle Aspiration Cytology
47%
Follicular Carcinoma
22%
Follicular Thyroid Adenoma
28%
Follicular Thyroid Carcinoma
34%
Genetic Screening
26%
Germline mutation
38%
Growth Hormone
23%
Human Prolactin
20%
Hyperparathyroidism
53%
Hyperparathyroidism-jaw Tumor Syndrome (HPT-JT)
30%
Hyperprolactinemia
42%
Immunoglobulin G
29%
Kindred
44%
Macroprolactinemia
41%
Medullary Thyroid Carcinoma
47%
Metastasis
24%
Minisequencing
24%
Molecular Diagnostics
23%
Monoclonal Origin
22%
Monomeric Prolactin
22%
Multiple Endocrine Neoplasia Type 1 (MEN1)
25%
Multiple Endocrine Neoplasia Type 2 (MEN2)
43%
Mutational Analysis
25%
Papillary Thyroid Carcinoma
83%
Parathormone
24%
Parathyroid Adenoma
31%
Parathyroid Carcinoma
28%
Parathyroid Tumors
37%
PAX8
40%
Peroxisome Proliferator-activated Receptor
30%
Pituitary
32%
Portuguese Patients
26%
Preoperative Diagnosis
40%
Primary Hyperparathyroidism (pHPT)
26%
Prolactin
100%
Prolactin Gene
20%
Prolactinoma
24%
Quantitative PCR
35%
Somatic mutation
23%
Sporadic Cases
30%
Thyroid Tumor
50%
Tumor
87%
Unusual Case
22%
X Chromosome Inactivation
25%
Medicine and Dentistry
Adrenal Tumor
20%
Cancer Syndrome
37%
Carcinoma
30%
Chronic Kidney Disease
20%
Clear Cell Renal Cell Carcinoma
20%
Cohort Effect
20%
Corticotropin
20%
Cushing Syndrome
40%
Diseases
23%
Fine-Needle Aspiration
49%
Follicular Carcinoma
22%
Germline Mutation
26%
Growth Hormone
20%
Homeostasis
20%
Hydrocortisone
33%
Hyperparathyroidism
37%
Hyperthyroidism
20%
Isotopes of Calcium
20%
Jaw Tumor
30%
Lung
20%
Luteinizing Hormone Receptor
20%
Medullary Carcinoma
20%
Messenger RNA
23%
Metastatic Breast Cancer
20%
Metastatic Carcinoma
24%
Molecular Diagnosis
23%
Multinodular Goitre
20%
Multiple Endocrine Neoplasia Type 2
20%
Neoplasm
52%
Papillary Carcinoma
20%
Papillary Thyroid Cancer
62%
Parathyroid Adenoma
23%
Parathyroid Hormone
23%
Parathyroid Tumor
23%
Pathophysiology
20%
Pentetreotide
20%
Peroxisome Proliferator Activated Receptor
30%
Prolactin
20%
Reverse Transcription Polymerase Chain Reaction
22%
Scintigraphy
24%
Skin Metastasis
20%
Somatic Mutation
23%
Somatostatin
20%
Thyroid Adenoma
28%
Thyroid Follicular Carcinoma
38%
Thyroid Medullary Carcinoma
37%
Thyroid Tumor
40%
Tumor
43%
Tumor Diagnosis
20%
X Chromosome Inactivation
23%
Biochemistry, Genetics and Molecular Biology
Allele
33%
Autoantibody
40%
Autoimmunity
20%
Autosomal Dominant Inheritance
23%
Blood Level
20%
CAG Repeat
10%
Chromosome 1
10%
Codon
38%
Comparative Genomic Hybridization
20%
Creatinine
10%
Deficiency
20%
Exon
14%
Gel Filtration
8%
Gene Linkage
30%
Gene Mutation
7%
Genetic Screening
30%
Genetics
60%
Germ Cell
30%
Germline
30%
Germline Mutation
29%
Haplotype
15%
Heterozygosity
15%
Homeostasis
20%
Hypocalcaemia
12%
Immunoassay
20%
Immunoglobulin G
17%
Immunostaining
10%
Isoprenaline
10%
Leukocyte
20%
Linkage Analysis
20%
Loss of Heterozygosity
22%
MEN1
20%
Metabolic Regulation
10%
Methylation
20%
Molecular Genetics
10%
Parathyroid Hormone
45%
Parathyroid Hormone Blood Level
20%
Phosphate Metabolism
10%
Pituitary-Specific Positive Transcription Factor 1
12%
Polymorphic Locus
10%
Prolactin
80%
Promoter Region
16%
Repressor
16%
Single-Nucleotide Polymorphism
20%
Somatic Mutation
10%
Thyroxine-Binding Globulin
20%
Tumor Gene
10%
Tumor Suppressor Gene
15%
Wilms' Tumor
10%
X-Inactivation
20%
